Orbem has secured €55.5 million in Series B funding to advance its goal of building a healthier and more sustainable future. The round was led by Innovation Industries and joined by Supernova Invest, with continued support from existing investors General Catalyst, 83NORTH, The Venture Collective (TVC) Collective, and Possible Ventures.
The company said it has scanned more than 170 million eggs for the poultry industry, positioning its technology as a non-invasive and sustainable alternative to chick culling. Orbem described the milestone as significant, but said it is “only getting started.”
Orbem plans to use the new capital to fuel its next phase of global expansion and product development. A key priority is accelerating entry into the U.S. market, where the company is establishing a presence through a new office in Houston as it brings its existing solutions to one of the world’s largest agricultural markets.
The company is also expanding its “Vertical AI” capabilities into the fruit and vegetable sector. Orbem said its technology can “see inside” produce such as avocados and mangoes to detect internal defects and assess quality without cutting items open.
In healthcare and data, Orbem said it is working to “industrialize MRI” while building what it describes as the world’s largest and most comprehensive biological dataset. The company said this dataset will serve as the foundation for applying actionable intelligence to help transform human healthcare.
Orbem said it remains the first and only company to demonstrate MRI at this speed, analyzing biological matter in under one second at industrial scale without a human in the loop. The company thanked its investors and teams in Munich and Houston, saying its work is helping the world “see from the inside out.”
